Therapeutic Vaccines Market Size, Trends, Analysis, and Outlook By Product (Autoimmune Disease Vaccines, Neurological Disease Vaccines, Cancer Vaccines, Infectious Disease Vaccines, Others), By Technology (Allogeneic Vaccine, Autologous Vaccine), by Region, Country, Segment, and Companies, 2024-2030
The global Therapeutic Vaccines market size is poised to register 13.11% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Therapeutic Vaccines market By Product (Autoimmune Disease Vaccines, Neurological Disease Vaccines, Cancer Vaccines, Infectious Disease Vaccines, Others), By Technology (Allogeneic Vaccine, Autologous Vaccine).
Therapeutic vaccines are experiencing significant advancements driven by advances in immunology, cancer biology, and vaccine technology, offering promising treatment options for a wide range of infectious diseases, chronic conditions, and cancers. Key trends shaping the future of the therapeutic vaccines market include the development of personalized cancer vaccines targeting tumor-specific antigens and neoantigens, leveraging next-generation sequencing and bioinformatics to identify patient-specific mutations and immune targets. Additionally, there is increasing interest in therapeutic vaccines for chronic viral infections, such as HIV, hepatitis B and C, and human papillomavirus (HPV), aimed at inducing durable immune responses and achieving functional cure or long-term viral suppression. Moreover, there is growing emphasis on combination immunotherapy approaches, including therapeutic vaccine combinations with immune checkpoint inhibitors, cytokine therapy, and adoptive cell therapy, to enhance antitumor immunity, overcome immune evasion mechanisms, and improve treatment response rates. Furthermore, there is ongoing research into novel vaccine platforms, delivery systems, and adjuvants, such as mRNA vaccines, viral vectors, and nanoparticles, to enhance vaccine immunogenicity, antigen presentation, and cross-priming of T cell responses. Overall, the future of the therapeutic vaccines market lies in the continued innovation and integration of precision medicine approaches, combination therapies, and advanced vaccine technologies that harness the power of the immune system to prevent and treat a diverse range of diseases and improve patient outcomes..
Therapeutic Vaccines Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Therapeutic Vaccines market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Therapeutic Vaccines survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Therapeutic Vaccines industry.
Key market trends defining the global Therapeutic Vaccines demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Therapeutic Vaccines Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Therapeutic Vaccines industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Therapeutic Vaccines companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Therapeutic Vaccines industry
Leading Therapeutic Vaccines companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Therapeutic Vaccines companies.
Therapeutic Vaccines Market Study- Strategic Analysis Review
The Therapeutic Vaccines market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Therapeutic Vaccines industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Therapeutic Vaccines Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Therapeutic Vaccines Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Therapeutic Vaccines market segments. Similarly, Strong end-user demand is encouraging Canadian Therapeutic Vaccines companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Therapeutic Vaccines market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Therapeutic Vaccines Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Therapeutic Vaccines industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Therapeutic Vaccines market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Therapeutic Vaccines Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Therapeutic Vaccines in Asia Pacific. In particular, China, India, and South East Asian Therapeutic Vaccines markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Therapeutic Vaccines Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Therapeutic Vaccines Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Therapeutic Vaccines market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Therapeutic Vaccines.
Therapeutic Vaccines Market Company Profiles
The global Therapeutic Vaccines market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Agenus Inc, Argos Therapeutic Inc, AstraZeneca Plc, BioNTech SE, Celldex Therapeutic Inc, Dendreon Corp , GlaxoSmithKline plc, INOVIO Pharmaceuticals, Merck & Co. Inc, Novartis AG, Pfizer Inc, Phio Pharmaceuticals Corp.
Recent Therapeutic Vaccines Market Developments
The global Therapeutic Vaccines market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Therapeutic Vaccines Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
Geographical Segmentation:
Agenus Inc
Argos Therapeutic Inc
AstraZeneca Plc
BioNTech SE
Celldex Therapeutic Inc
Dendreon Corp
GlaxoSmithKline plc
INOVIO Pharmaceuticals
Merck & Co. Inc
Novartis AG
Pfizer Inc
Phio Pharmaceuticals Corp
Formats Available: Excel, PDF, and PPT
Therapeutic vaccines are experiencing significant advancements driven by advances in immunology, cancer biology, and vaccine technology, offering promising treatment options for a wide range of infectious diseases, chronic conditions, and cancers. Key trends shaping the future of the therapeutic vaccines market include the development of personalized cancer vaccines targeting tumor-specific antigens and neoantigens, leveraging next-generation sequencing and bioinformatics to identify patient-specific mutations and immune targets. Additionally, there is increasing interest in therapeutic vaccines for chronic viral infections, such as HIV, hepatitis B and C, and human papillomavirus (HPV), aimed at inducing durable immune responses and achieving functional cure or long-term viral suppression. Moreover, there is growing emphasis on combination immunotherapy approaches, including therapeutic vaccine combinations with immune checkpoint inhibitors, cytokine therapy, and adoptive cell therapy, to enhance antitumor immunity, overcome immune evasion mechanisms, and improve treatment response rates. Furthermore, there is ongoing research into novel vaccine platforms, delivery systems, and adjuvants, such as mRNA vaccines, viral vectors, and nanoparticles, to enhance vaccine immunogenicity, antigen presentation, and cross-priming of T cell responses. Overall, the future of the therapeutic vaccines market lies in the continued innovation and integration of precision medicine approaches, combination therapies, and advanced vaccine technologies that harness the power of the immune system to prevent and treat a diverse range of diseases and improve patient outcomes..
Therapeutic Vaccines Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Therapeutic Vaccines market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Therapeutic Vaccines survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Therapeutic Vaccines industry.
Key market trends defining the global Therapeutic Vaccines demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Therapeutic Vaccines Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Therapeutic Vaccines industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Therapeutic Vaccines companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Therapeutic Vaccines industry
Leading Therapeutic Vaccines companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Therapeutic Vaccines companies.
Therapeutic Vaccines Market Study- Strategic Analysis Review
The Therapeutic Vaccines market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Therapeutic Vaccines industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Therapeutic Vaccines Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Therapeutic Vaccines Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Therapeutic Vaccines market segments. Similarly, Strong end-user demand is encouraging Canadian Therapeutic Vaccines companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Therapeutic Vaccines market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Therapeutic Vaccines Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Therapeutic Vaccines industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Therapeutic Vaccines market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Therapeutic Vaccines Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Therapeutic Vaccines in Asia Pacific. In particular, China, India, and South East Asian Therapeutic Vaccines markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Therapeutic Vaccines Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Therapeutic Vaccines Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Therapeutic Vaccines market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Therapeutic Vaccines.
Therapeutic Vaccines Market Company Profiles
The global Therapeutic Vaccines market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Agenus Inc, Argos Therapeutic Inc, AstraZeneca Plc, BioNTech SE, Celldex Therapeutic Inc, Dendreon Corp , GlaxoSmithKline plc, INOVIO Pharmaceuticals, Merck & Co. Inc, Novartis AG, Pfizer Inc, Phio Pharmaceuticals Corp.
Recent Therapeutic Vaccines Market Developments
The global Therapeutic Vaccines market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Therapeutic Vaccines Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Agenus Inc
Argos Therapeutic Inc
AstraZeneca Plc
BioNTech SE
Celldex Therapeutic Inc
Dendreon Corp
GlaxoSmithKline plc
INOVIO Pharmaceuticals
Merck & Co. Inc
Novartis AG
Pfizer Inc
Phio Pharmaceuticals Corp
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Therapeutic Vaccines Market Overview and Key Findings, 2024
1.2 Therapeutic Vaccines Market Size and Growth Outlook, 2021- 2030
1.3 Therapeutic Vaccines Market Growth Opportunities to 2030
1.4 Key Therapeutic Vaccines Market Trends and Challenges
1.4.1 Therapeutic Vaccines Market Drivers and Trends
1.4.2 Therapeutic Vaccines Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Therapeutic Vaccines Companies
2. THERAPEUTIC VACCINES MARKET SIZE OUTLOOK TO 2030
2.1 Therapeutic Vaccines Market Size Outlook, USD Million, 2021- 2030
2.2 Therapeutic Vaccines Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. THERAPEUTIC VACCINES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. THERAPEUTIC VACCINES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Therapeutic Vaccines Market, 2025
5.2 Asia Pacific Therapeutic Vaccines Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Therapeutic Vaccines Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Therapeutic Vaccines Market, 2025
5.5 Europe Therapeutic Vaccines Market Size Outlook by Type, 2021- 2030
5.6 Europe Therapeutic Vaccines Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Therapeutic Vaccines Market, 2025
5.8 North America Therapeutic Vaccines Market Size Outlook by Type, 2021- 2030
5.9 North America Therapeutic Vaccines Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Therapeutic Vaccines Market, 2025
5.11 South America Pacific Therapeutic Vaccines Market Size Outlook by Type, 2021- 2030
5.12 South America Therapeutic Vaccines Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Therapeutic Vaccines Market, 2025
5.14 Middle East Africa Therapeutic Vaccines Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Therapeutic Vaccines Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Therapeutic Vaccines Market Size Outlook and Revenue Growth Forecasts
6.2 US Therapeutic Vaccines Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Therapeutic Vaccines Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Therapeutic Vaccines Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Therapeutic Vaccines Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Therapeutic Vaccines Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Therapeutic Vaccines Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Therapeutic Vaccines Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Therapeutic Vaccines Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Therapeutic Vaccines Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Therapeutic Vaccines Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Therapeutic Vaccines Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Therapeutic Vaccines Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Therapeutic Vaccines Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Therapeutic Vaccines Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Therapeutic Vaccines Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Therapeutic Vaccines Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Therapeutic Vaccines Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Therapeutic Vaccines Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Therapeutic Vaccines Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Therapeutic Vaccines Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Therapeutic Vaccines Industry Drivers and Opportunities
7. THERAPEUTIC VACCINES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. THERAPEUTIC VACCINES COMPANY PROFILES
8.1 Profiles of Leading Therapeutic Vaccines Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Agenus Inc
Argos Therapeutic Inc
AstraZeneca Plc
BioNTech SE
Celldex Therapeutic Inc
Dendreon Corp
GlaxoSmithKline plc
INOVIO Pharmaceuticals
Merck & Co. Inc
Novartis AG
Pfizer Inc
Phio Pharmaceuticals Corp
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Therapeutic Vaccines Market Overview and Key Findings, 2024
1.2 Therapeutic Vaccines Market Size and Growth Outlook, 2021- 2030
1.3 Therapeutic Vaccines Market Growth Opportunities to 2030
1.4 Key Therapeutic Vaccines Market Trends and Challenges
1.4.1 Therapeutic Vaccines Market Drivers and Trends
1.4.2 Therapeutic Vaccines Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Therapeutic Vaccines Companies
2. THERAPEUTIC VACCINES MARKET SIZE OUTLOOK TO 2030
2.1 Therapeutic Vaccines Market Size Outlook, USD Million, 2021- 2030
2.2 Therapeutic Vaccines Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. THERAPEUTIC VACCINES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. THERAPEUTIC VACCINES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Therapeutic Vaccines Market, 2025
5.2 Asia Pacific Therapeutic Vaccines Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Therapeutic Vaccines Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Therapeutic Vaccines Market, 2025
5.5 Europe Therapeutic Vaccines Market Size Outlook by Type, 2021- 2030
5.6 Europe Therapeutic Vaccines Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Therapeutic Vaccines Market, 2025
5.8 North America Therapeutic Vaccines Market Size Outlook by Type, 2021- 2030
5.9 North America Therapeutic Vaccines Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Therapeutic Vaccines Market, 2025
5.11 South America Pacific Therapeutic Vaccines Market Size Outlook by Type, 2021- 2030
5.12 South America Therapeutic Vaccines Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Therapeutic Vaccines Market, 2025
5.14 Middle East Africa Therapeutic Vaccines Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Therapeutic Vaccines Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Therapeutic Vaccines Market Size Outlook and Revenue Growth Forecasts
6.2 US Therapeutic Vaccines Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Therapeutic Vaccines Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Therapeutic Vaccines Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Therapeutic Vaccines Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Therapeutic Vaccines Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Therapeutic Vaccines Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Therapeutic Vaccines Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Therapeutic Vaccines Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Therapeutic Vaccines Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Therapeutic Vaccines Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Therapeutic Vaccines Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Therapeutic Vaccines Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Therapeutic Vaccines Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Therapeutic Vaccines Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Therapeutic Vaccines Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Therapeutic Vaccines Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Therapeutic Vaccines Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Therapeutic Vaccines Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Therapeutic Vaccines Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Therapeutic Vaccines Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Therapeutic Vaccines Industry Drivers and Opportunities
7. THERAPEUTIC VACCINES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. THERAPEUTIC VACCINES COMPANY PROFILES
8.1 Profiles of Leading Therapeutic Vaccines Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Agenus Inc
Argos Therapeutic Inc
AstraZeneca Plc
BioNTech SE
Celldex Therapeutic Inc
Dendreon Corp
GlaxoSmithKline plc
INOVIO Pharmaceuticals
Merck & Co. Inc
Novartis AG
Pfizer Inc
Phio Pharmaceuticals Corp
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
